Activation of stem cell up-regulation/mobilization: a cardiovascular risk in both mice and humans with implications for liver disease, psoriasis and SLE

References

• Dutta P, Courties G, Wei Y, et al. Myocardial infarction accelerates atherosclerosis. Nature. 2012;487(7407):325–329. doi:10.1038/nature1126022763456
   PubMed Web of Science ®Google Scholar
• Heidt T, Sager HB, Courties G, et al. Chronic variable stress activates hematopoietic stem cells. Nat Med. 2014;20(7):754–758. doi:10.1038/nm.358924952646
   PubMed Web of Science ®Google Scholar
• Brunham LR, Singaraja RR, Duong M, et al. Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29(4):548–554. doi:10.1161/ATVBAHA.108.18230319201688
   PubMed Web of Science ®Google Scholar
• Westerterp M, Gourion-Arsiquaud S, Murphy AJ, et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell. 2012;11(2):195–206. doi:10.1016/j.stem.2012.04.02422862945
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Ranalletta M, Wang N, et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest. 2007;117(12):3900–3908. doi:10.1172/JCI3337217992262
   PubMed Web of Science ®Google Scholar
• Platzbecker U, Prange-Krex G, Bornhauser M, et al. Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion (Paris). 2001;41(2):184–189.
   Web of Science ®Google Scholar
• Katsaros KM, Speidl WS, Demyanets S, et al. G-CSF predicts cardiovascular events in patients with stable coronary artery disease. PLoS One. 2015;10(11):e0142532. doi:10.1371/journal.pone.014253226555480
   PubMed Web of Science ®Google Scholar
• Bazarniy VV, Garenskikh NV. The diagnostic value of identification of granulocytic colony-stimulating factor under hepatocirrhosis [Article in Russian; English Translation available by request to the corresponding author]. Klin Lab Diagn. 2013;5:3–5.
   Google Scholar
• Kaya AO, Coskun U, Sancak B, et al. Increased serum granulocyte colony stimulating factor in Turkish hepatocellular carcinoma patients. Asian Pac J Cancer Prev. 2009;10(3):403–406.19640182
   PubMedGoogle Scholar
• Loria P, Marchesini G, Nascimbeni F, et al. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Atherosclerosis. 2014;232(1):99–109. doi:10.1016/j.atherosclerosis.2013.10.03024401223
   PubMed Web of Science ®Google Scholar
• Chen XQ, Yu YC, Deng HH, et al. Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity. J Clin Immunol. 2010;30(2):221–225. doi:10.1007/s10875-009-9365-x20107878
   PubMed Web of Science ®Google Scholar
• Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses’ health study. Arthritis Rheum. 2009;61(10):1396–1402. doi:10.1002/art.2453719790130
   PubMed Web of Science ®Google Scholar
• Hwang YJ, Jung HJ, Kim MJ, et al. Serum levels of LL-37 and inflammatory cytokines in plaque and guttate psoriasis. Mediators Inflamm. 2014;2014:268257. doi:10.1155/2014/26825725197165
   PubMed Web of Science ®Google Scholar
• Mahiques-Santos L, Soriano-Navarro CJ, Perez-Pastor G, Tomas-Cabedo G, Pitarch-Bort G, Valcuende-Cavero F. Psoriasis and ischemic coronary artery disease. Actas Dermosifiliogr. 2015;106(2):112–116. doi:10.1016/j.ad.2014.08.00225304822
   PubMedGoogle Scholar
• Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol. 2010;35(6):645–649. doi:10.1111/j.1365-2230.2009.03704.x19843085
   PubMed Web of Science ®Google Scholar
• Wen Z, Xu L, Xu W, Xiong S. Detection of dynamic frequencies of Th17 cells and their associations with clinical parameters in patients with systemic lupus erythematosus receiving standard therapy. Clin Rheumatol. 2014;33(10):1451–1458. doi:10.1007/s10067-014-2656-524810699
   PubMed Web of Science ®Google Scholar
• Arai M, Misao Y, Nagai H, et al. Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease. Circ J. 2006;70(9):1093–1098.16936417
   PubMed Web of Science ®Google Scholar
• Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis. 2010;209(1):10–17. doi:10.1016/j.atherosclerosis.2009.08.03319740466
   PubMed Web of Science ®Google Scholar
• Hill JM, Syed MA, Arai AE, et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol. 2005;46(9):1643–1648. doi:10.1016/j.jacc.2005.01.06716256862
   PubMed Web of Science ®Google Scholar
• Clee SM, Kastelein JJ, van Dam M, et al. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest. 2000;106(10):1263–1270. doi:10.1172/JCI1072711086027
   PubMed Web of Science ®Google Scholar
• McMahon M, Hahn BH, Skaggs BJ. Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention. Expert Rev Clin Immunol. 2011;7(2):227–241. doi:10.1586/eci.10.9821426260
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735–1741. doi:10.1001/jama.296.14.173517032986
   PubMed Web of Science ®Google Scholar
• Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the general practice research database. Eur Heart J. 2010;31(8):1000–1006. doi:10.1093/eurheartj/ehp56720037179
   PubMed Web of Science ®Google Scholar
• Puchner SB, Lu MT, Mayrhofer T, et al. High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial. Radiology. 2015;274(3):693–701. doi:10.1148/radiol.1414093325369449
   PubMed Web of Science ®Google Scholar
• Tarantino G, Costantini S, Finelli C, et al. Is serum Interleukin-17 associated with early atherosclerosis in obese patients? J Transl Med. 2014;12:214. doi:10.1186/s12967-014-0214-125092442
   PubMed Web of Science ®Google Scholar
• Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology. 2000;32(1):11–16. doi:10.1053/jhep.2000.912410869283
   PubMed Web of Science ®Google Scholar
• Alison MR, Poulsom R, Jeffery R, et al. Hepatocytes from non-hepatic adult stem cells. Nature. 2000;406(6793):257. doi:10.1038/3502055710917519
   PubMed Web of Science ®Google Scholar
• Poulsom R, Forbes SJ, Hodivala-Dilke K, et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol. 2001;195(2):229–235. doi:10.1002/path.97611592103
   PubMed Web of Science ®Google Scholar
• Lemoli RM, Catani L, Talarico S, et al. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells. 2006;24(12):2817–2825. doi:10.1634/stemcells.2006-033316931769
   PubMed Web of Science ®Google Scholar
• Stoiser B, Looareesuwan S, Thalhammer F, et al. Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria. Eur Cytokine Netw. 2000;11(1):75–80.10705302
   PubMed Web of Science ®Google Scholar
• Kohno M, Shirabe K, Mano Y, et al. Granulocyte colony-stimulating-factor-producing hepatocellular carcinoma with extensive sarcomatous changes: report of a case. Surg Today. 2013;43(4):439–445. doi:10.1007/s00595-012-0202-022638568
   PubMed Web of Science ®Google Scholar
• El Husseiny NM, Fahmy HM, Mohamed WA, Amin HH. Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians. World J Hepatol. 2012;4(8):242–247. doi:10.4254/wjh.v4.i8.24222993666
   PubMedGoogle Scholar
• Lemmers A, Moreno C, Gustot T, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49(2):646–657. doi:10.1002/hep.2268019177575
   PubMed Web of Science ®Google Scholar
• Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS, Jia JH. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 2012;19(6):396–403. doi:10.1111/j.1365-2893.2011.01561.x22571901
   PubMed Web of Science ®Google Scholar
• Huda W, ed. Review of Radiologic Physics, 4th Edition. Philadelphia, PA: Wolters Kluwer; 2016.
   Google Scholar
• Kargulewicz A, Stankowiak-Kulpa H, Grzymislawski M. Dietary recommendations for patients with nonalcoholic fatty liver disease. Prz Gastroenterol. 2014;9(1):18–23. doi:10.5114/pg.2014.4084524868294
   PubMedGoogle Scholar
• Chen DY, Chen YM, Wen MC, Hsieh TY, Hung WT, Lan JL. The potential role of Th17 cells and Th17-related cytokines in the pathogenesis of lupus nephritis. Lupus. 2012;21(13):1385–1396. doi:10.1177/096120331245771822892208
   PubMed Web of Science ®Google Scholar
• Crispin JC, Tsokos GC. IL-17 in systemic lupus erythematosus. J Biomed Biotechnol. 2010;2010:943254. doi:10.1155/2010/94325420379379
   PubMedGoogle Scholar
• Hellmich B, Csernok E, de Haas M, et al. Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty’s syndrome or systemic lupus erythematosus. Am J Med. 2002;113(2):134–139.12133752
   PubMed Web of Science ®Google Scholar
• Rana A, Minz RW, Aggarwal R, Anand S, Pasricha N, Singh S. Gene expression of cytokines (TNF-alpha, IFN-gamma), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus. Lupus. 2012;21(10):1105–1112. doi:10.1177/096120331245120022759859
   PubMed Web of Science ®Google Scholar
• Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol. 2008;127(3):385–393. doi:10.1016/j.clim.2008.01.01918373953
   PubMed Web of Science ®Google Scholar
• Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol. 1997;145(5):408–415. doi:10.1093/oxfordjournals.aje.a0091229048514
   PubMed Web of Science ®Google Scholar
• Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore). 1989;68(3):141–150.2785628
   PubMed Web of Science ®Google Scholar
• Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349(25):2399–2406. doi:10.1056/NEJMoa03547114681505
   PubMed Web of Science ®Google Scholar
• Petri MA, Kiani AN, Post W, Christopher-Stine L, Magder LS. Lupus Atherosclerosis Prevention Study (LAPS). Ann Rheum Dis. 2011;70(5):760–765. doi:10.1136/ard.2010.13676221177297
   PubMed Web of Science ®Google Scholar
• Moonen JR, de Leeuw K, van Seijen XJ, et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther. 2007;9(4):R84. doi:10.1186/ar217217764548
   PubMed Web of Science ®Google Scholar
• Robbins CS, Chudnovskiy A, Rauch PJ, et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation. 2012;125(2):364–374. doi:10.1161/CIRCULATIONAHA.111.06198622144566
   PubMed Web of Science ®Google Scholar
• Armstrong AW, Schupp C, Bebo B. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology. 2012;225(2):121–126. doi:10.1159/00034218023108113
   PubMed Web of Science ®Google Scholar
• Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005;2005(5):273–279. doi:10.1155/MI.2005.27316258194
   PubMed Web of Science ®Google Scholar
• Michalak-Stoma A, Bartosinska J, Kowal M, Juszkiewicz-Borowiec M, Gerkowicz A, Chodorowska G. Serum levels of selected Th17 and Th22 cytokines in psoriatic patients. Dis Markers. 2013;35(6):625–631. doi:10.1155/2013/85605624288431
   PubMedGoogle Scholar
• El-Moaty Zaher HA, El-Komy MH, Hegazy RA, Mohamed El Khashab HA, Ahmed HH. Assessment of interleukin-17 and vitamin D serum levels in psoriatic patients. J Am Acad Dermatol. 2013;69(5):840–842. doi:10.1016/j.jaad.2013.07.02624124829
   PubMed Web of Science ®Google Scholar
• Kyriakou A, Patsatsi A, Vyzantiadis TA, Sotiriadis D. Serum levels of TNF-alpha, IL-12/23p40, and IL-17 in plaque psoriasis and their correlation with disease severity. J Immunol Res. 2014;2014:467541. doi:10.1155/2014/39412725759829
   PubMed Web of Science ®Google Scholar
• Rungapiromnan W, Yiu ZZN, Warren RB, Griffiths CEM, Ashcroft DM. Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2017;176(4):890–901. doi:10.1111/bjd.1496427518205
   PubMed Web of Science ®Google Scholar
• Papp KA, Griffiths CE, Gordon K, et al. Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol. 2013;168(4):844–854. doi:10.1111/bjd.1221423301632
   PubMed Web of Science ®Google Scholar
• Gelfand JM, Takeshita J, Dey A, Shin D, Noe M. Eastern regional meeting (A phase IV, randomised, double-blind, placebo-controlled crossover study of the effects of ustekinumab on vascular inflammation in psoriasis (The VIP-U Trial)). J Investig Med. 2018;2018(66):697–719.
   Google Scholar
• Westerterp M, Murphy AJ, Wang M, et al. Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice. Circ Res. 2013;112(11):1456–1465. doi:10.1161/CIRCRESAHA.113.30108623572498
   PubMed Web of Science ®Google Scholar